[EXECUTION VERSION Amendment Amended and Restated Pledge Agreement Seaspan Investment Grantor Collateral Agent This FIRST AMENDMENT TO THE AMENDED AND RESTATED SEASPAN INVESTMENT PLEDGE AND COLLATERAL AGENT AGREEMENT (this RECITALS NOW, THEREFORE, in consideration of the premises and for other good]
[1 Announcement dated August 10, 2018 in respect of Change of Important Executive Positions. build-out the Companys ability to effectively sustain its growth and to achieve or enhance profitability; changes in the PRC telecommunications industry resulting from the issuance of licenses for tele]
[EXECUTION VERSION Amendment Amended and Restated Pledge Agreement Seaspan Investment Grantor Collateral Agent This FIRST AMENDMENT TO THE AMENDED AND RESTATED SEASPAN INVESTMENT PLEDGE AND COLLATERAL AGENT AGREEMENT (this RECITALS NOW, THEREFORE, in consideration of the premises and for other good]
[001-31914 中國人壽保險股份有限公司 CHINA LIFE INSURANCE COMPANY LIMITED (A joint stock limited company incorporated in the Peoples Republic of China with limited liability) (Stock code: 2628) ANNOUNCEMENT OF PREMIUM INCOME Reference is made to the Companys announcement dated 27 August 2004. The above informat]
[001-31914 中國人壽保險股份有限公司 CHINA LIFE INSURANCE COMPANY LIMITED (A joint stock limited company incorporated in the Peoples Republic of China with limited liability) (Stock code: 2628) ANNOUNCEMENT OF PREMIUM INCOME Reference is made to the Companys announcement dated 27 August 2004. The above informat]
[FOR RELEASE August 13, 2018 China Biologic Names Bing Li as New CEO BEIJING, China — August 13, 2018 — Mr. David Hui Li, Chairman of China Biologic, stated, “I am very pleased that Dr. Li has agreed to take the position of Chief Executive Officer. I believe, with his extensive expertise in the pharm]
[] [SARBANES-OXLEY ACT OF 2002 I, Edward Yihua Kang, certify that: 1. I have reviewed this quarterly report on Form 10-Q for the period ended June 30, 2018 of Ever-Glory International Group, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit t]
[FOR RELEASE August 13, 2018 China Biologic Names Bing Li as New CEO BEIJING, China — August 13, 2018 — Mr. David Hui Li, Chairman of China Biologic, stated, “I am very pleased that Dr. Li has agreed to take the position of Chief Executive Officer. I believe, with his extensive expertise in the pharm]
[] [SARBANES-OXLEY ACT OF 2002 I, Edward Yihua Kang, certify that: 1. I have reviewed this quarterly report on Form 10-Q for the period ended June 30, 2018 of Ever-Glory International Group, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit t]
